HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epithelial-mesenchymal transition contributes to docetaxel resistance in human non-small cell lung cancer.

Abstract
Lung cancer is an aggressive malignancy with high morbidity and mortality. Chemotherapy has always been the principal treatment measure, but its acquired resistance becomes a critical problem. In the current study, we established a new docetaxel-resistant human non-small lung cancer (NSCLC) cell line A549/Docetaxel. The resistance index (RI) of A549/Docetaxel cells and A549 induced by TGF-β to docetaxel were 8.91 and 11.5, respectively. Compared to the parental A549 cells, the multiplication time of A549/Docetaxel was prolonged, the proportion of the cell cycle in the S phase decreased while that in the G1 phase increased, and apoptotic rate was much lower. The morphology of the resistant cells eventuated epithelial-mesenchymal transition (EMT), which was confirmed by the higher expression of fibronectin, vimentin (mesenchymal markers), and lower expression of E-cadherin (epithelial marker) at mRNA and proteins levels. Furthermore, the representative markers for docetaxel resistance were examined, including ABCB1 (MDR1), Bcl-2, Bax, and tubulin, to figure out the mechanisms of the resistance of A549/Docetaxel. In summary, we have established a typical docetaxel-resistant human NSCLC cell line A549/Docetaxel, and it was suggested that the multidrug resistance of A549/Docetaxel was related to EMT.
AuthorsWeiwei Shen, Hailin Pang, Jiayu Liu, Jing Zhou, Feng Zhang, Lele Liu, Ningqiang Ma, Ning Zhang, Helong Zhang, Lili Liu
JournalOncology research (Oncol Res) Vol. 22 Issue 1 Pg. 47-55 ( 2014) ISSN: 1555-3906 [Electronic] United States
PMID25700358 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Biomarkers, Tumor
  • Cadherins
  • Fibronectins
  • Proto-Oncogene Proteins c-bcl-2
  • Taxoids
  • Transforming Growth Factor beta
  • Tubulin
  • Vimentin
  • bcl-2-Associated X Protein
  • Docetaxel
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (metabolism)
  • Apoptosis
  • Biomarkers, Tumor (metabolism)
  • Cadherins (metabolism)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, pathology)
  • Cell Cycle
  • Cell Growth Processes
  • Cell Line, Tumor
  • Docetaxel
  • Drug Resistance, Neoplasm (physiology)
  • Epithelial-Mesenchymal Transition
  • Fibronectins (metabolism)
  • Humans
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Taxoids (pharmacology)
  • Transforming Growth Factor beta (metabolism)
  • Tubulin (metabolism)
  • Vimentin (metabolism)
  • bcl-2-Associated X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: